Vasculitis
Yusuf Yazici, MD
New York University School of Medicine
La Jolla, CA, United States
Disclosure(s): Amgen: Consultant (Ongoing)
Cristina Ponte, MD, PhD
Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte
Lisbon, Portugal
Disclosure information not submitted.
Peter Merkel, MD, MPH
University of Pennsylvania
Philadelphia, PA, United States
Disclosure(s): AbbVie: Consultant (Ongoing), Grant/Research Support (Ongoing); AstraZeneca: Consultant (Ongoing), Grant/Research Support (Ongoing); Boeringher-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb: Consultant (Ongoing), Grant/Research Support (Ongoing); ChemoCentryx: Consultant (Ongoing), Grant/Research Support (Ongoing); CSL Behring: Consultant (Ongoing); Dynacure: Consultant (Ongoing); Eicos: Grant/Research Support (Ongoing); Electra: Grant/Research Support (Ongoing); EMDSerono: Consultant (Terminated, December 31, 2021); Forbius: Consultant (Terminated, December 31, 2021), Grant/Research Support (Terminated, December 31, 2021); Genentech/Roche: Consultant (Terminated, December 31, 2021), Grant/Research Support (Terminated, December 31, 2021); Genzyme/Sanofi: Consultant (Terminated, December 31, 2021), Grant/Research Support (Terminated, December 31, 2021); GlaxoSmithKline: Consultant (Ongoing), Grant/Research Support (Ongoing); Immagene: Consultant (Ongoing); InflaRx: Consultant (Ongoing), Grant/Research Support (Ongoing); Jannsen: Consultant (Ongoing); Kiniksa: Consultant (Terminated, July 31, 2020); Kyverna: Consultant (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Magenta: Consultant (Ongoing); Neutrolis: Consultant (Ongoing), Grant/Research Support (Ongoing); Novartis: Consultant (Ongoing); Pfizer: Consultant (Ongoing); Q32: Consultant (Ongoing); Regeneron: Consultant (Ongoing); Sparrow: Consultant (Ongoing); Takeda: Consultant (Ongoing), Grant/Research Support (Ongoing); UpToDate: Royalties (Ongoing)
Kaitlin Quinn, MD, MHS
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
Washington, DC, United States
Disclosure information not submitted.
Digest of the ACR Convergence abstracts on large-vessel vasculitis and other large-vessel vasculitides
- Highlight of the most interesting research / important and emerging themes
- Comment on what to expect in the ACR Convergence sessions related to large-vessel vasculitis
- Generate discussion, including directly with some of the lead investigators on the highlighted abstracts, including for both oral presentations and posters